Strados Labs, a medical technology company harnessing the power of smart sensors, machine learning and proprietary algorithms to provide early detection and predictions of worsening respiratory diseases, today announced its pre-series A round of funding at $4.5M. Investors in the round included SOSV, cultivate(MD), Wavemaker360 Health, Blu Venture Investors and Broad Street Angels.
Â
